14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.48 $4.41 Friday, 3rd May 2024 EVAX stock ended at $3.95. This is 1.54% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.64% from a day low at $3.85 to a day high of $3.99.
90 days $2.82 $4.74
52 weeks $0.470 $13.55

Historical Evaxion Biotech A/S prices

Date Open High Low Close Volume
Jan 17, 2024 $0.790 $0.85 $0.750 $0.766 79 743
Jan 16, 2024 $0.80 $0.84 $0.760 $0.795 164 162
Jan 12, 2024 $0.750 $0.81 $0.750 $0.799 32 935
Jan 11, 2024 $0.757 $0.790 $0.720 $0.749 26 053
Jan 10, 2024 $0.710 $0.770 $0.710 $0.754 74 383
Jan 09, 2024 $0.684 $0.780 $0.684 $0.721 68 006
Jan 08, 2024 $0.80 $0.80 $0.730 $0.767 45 134
Jan 05, 2024 $0.770 $0.770 $0.730 $0.759 18 514
Jan 04, 2024 $0.730 $0.770 $0.700 $0.770 45 215
Jan 03, 2024 $0.718 $0.760 $0.700 $0.739 19 191
Jan 02, 2024 $0.82 $0.82 $0.670 $0.730 43 472
Dec 29, 2023 $0.690 $0.710 $0.675 $0.686 48 075
Dec 28, 2023 $0.680 $0.710 $0.680 $0.700 29 475
Dec 27, 2023 $0.692 $0.700 $0.670 $0.700 40 277
Dec 26, 2023 $0.705 $0.720 $0.705 $0.705 32 879
Dec 22, 2023 $0.687 $0.710 $0.678 $0.710 97 513
Dec 21, 2023 $0.670 $0.692 $0.660 $0.689 42 592
Dec 20, 2023 $0.660 $0.680 $0.630 $0.665 74 233
Dec 19, 2023 $0.690 $0.700 $0.621 $0.622 137 587
Dec 18, 2023 $0.660 $0.690 $0.641 $0.641 28 783
Dec 15, 2023 $0.660 $0.685 $0.660 $0.660 33 106
Dec 14, 2023 $0.670 $0.700 $0.661 $0.685 39 625
Dec 13, 2023 $0.689 $0.697 $0.660 $0.680 25 075
Dec 12, 2023 $0.660 $0.687 $0.651 $0.660 28 022
Dec 11, 2023 $0.660 $0.700 $0.620 $0.699 71 062
Click to get the best stock tips daily for free!

About Evaxion Biotech A/S

Evaxion Biotech A/S Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various... EVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT